MRVI Stock: Earnings, Dividends & Analyst Estimates

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $2.55 - $9.42

5.9 Year MRVI Performance Metrics:

Total Return (with DRIP): -74.3% (-20.59% CAGR)

Total Return (no DRIP): -74.3% (-20.59% CAGR)

Share Price: -74.3% (-20.59% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $2,566

Total Return $ (with DRIP): -$7,434

MRVI Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

MRVI Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for MRVI

Based on past 5.9-year performance, here are MRVI growth metrics:

Share price CAGR of -20.59%
Dividend CAGR of +0%

Using MRVI CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	MRVI (DRIP)	MRVI - No DRIP
Current Price	$7.66	$7.66
Start Shares	1,305.48	1,305.48
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	1,305.48	1,305.48
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.76	$7.66
Total Dividends	$0	$0
Final Value	$997	$10,000

Estimated Future Value + Dividends - MRVI

NOTE: Above numbers are our estimate based on MRVI's Dividend and Price CAGR over past 5.9 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) had its IPO on , and is traded on NASDAQ stock exchange.

Maravai LifeSciences Holdings, Inc. Class A Common Stock represents ownership in Maravai LifeSciences Holdings, Inc., a life sciences company focused on products and services that support drug development, vaccine creation, cell and gene therapy research, and diagnostics. The company serves biopharmaceutical, biotechnology, and research customers through specialized offerings in nucleic acid production and biologics safety testing. Its product portfolio includes reagents, enzymes, nucleic acid tools, and analytical services used across molecular biology, genomics, and bioprocessing workflows. Maravai LifeSciences plays a role in the broader healthcare and life sciences market by supplying critical inputs that help enable laboratory research, therapeutic development, and quality testing across the drug development process. The company is headquartered in San Diego, California, and its business is organized around current operating segments that address research and production needs in advanced biologics and diagnostics.

MRVI website: https://www.maravai.com